Tunitas Therapeutics Expands Board of Directors with Appointment of Dr. Mervyn Turner

Tunitas Therapeutics Appoints David J. King as Senior Vice President, Research

Tunitas Therapeutics Closes $10 Million Series A Financing

DSM and Tunitas Therapeutics Sign Agreement to Develop Lead Allergy Therapeutic

Tunitas Therapeutics Awarded Phase II SBIR Grant to Advance Asthma Program